Anavex Life Sciences Corp. (AVXL)
4.06
-0.14
(-3.33%)
USD |
NASDAQ |
Mar 20, 16:00
4.075
+0.02
(+0.37%)
After-Hours: 20:00
Anavex Life Sciences Market Cap : 376.25M for March 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nephros, Inc. | 30.97M |
| Becton, Dickinson & Co. | 43.84B |
| Cabaletta Bio, Inc. | 283.02M |
| ACADIA Pharmaceuticals, Inc. | 3.536B |
| Alnylam Pharmaceuticals, Inc. | 41.40B |
Market Cap Related Metrics
| Price to Book Value | 2.972 |
| Price | 4.06 |
| Earnings Yield | -11.45% |